ADMA Biologics, Inc. ADMA
Set alert
11.06 USD -0.35 -3.07%
At close · Nov 2
11.00 -0.06 -0.54%
After hours · Nov 2, 4:45 PM ET
11.05 Day range 11.59
7.21 52-week range 20.46
- YTD
- -39.36%
- 1 year
- -28.55%
- Open
- 11.42
- Prev close
- 11.41
- Mkt cap
- 2.48B
- Vol
- 2.89M
- Avg vol
- 2.69M
- EPS
- 0.70
- P/E
- 15.80
- Div yield
- 0.00%
More statistics
- Low
- 11.05
- High
- 11.59
- Forward P/E
- 11.72
- Beta
- 0.66
- Short ratio
- 5.82
- Inst. own
- 92.54%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 10.00
- 200-d avg
- 10.96
- 1y target
- 17.00
5D chart
Signals (75)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 11:35 AM | 12 hours ago |
| MACD: Sell Signal | Nov 2, 11:35 AM | 12 hours ago |
| MACD: Buy Signal | Nov 2, 11:20 AM | 12 hours ago |
| SMA: Bullish | Nov 2, 11:15 AM | 12 hours ago |
| SMA: Bearish | Nov 2, 11:10 AM | 12 hours ago |
| MACD: Sell Signal | Nov 2, 11:10 AM | 12 hours ago |
| SMA: Bullish | Nov 2, 11:00 AM | 12 hours ago |
| MACD: Buy Signal | Nov 2, 11:00 AM | 12 hours ago |
| MACD: Sell Signal | Nov 2, 10:40 AM | 13 hours ago |
| SMA: Bearish | Nov 2, 10:30 AM | 13 hours ago |
| RSI: Overbought | Nov 2, 9:50 AM | 14 hours ago |
| SMA: Bullish | Nov 2, 9:45 AM | 14 hours ago |
| SMA: Bullish | Nov 2, 9:45 AM | 14 hours ago |
| SMA: Bullish | Oct 30, 3:20 PM | 3 days ago |
| SMA: Bearish | Oct 30, 3:15 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 2:55 PM | 3 days ago |
| RSI: Oversold | Oct 30, 2:25 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 2:15 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 2:00 PM | 3 days ago |
| RSI: Oversold | Oct 30, 12:55 PM | 3 days ago |
Newest 20 of 75.
Financial health
Altman Z-Score
7.85 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
6 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B+3 / 5 overall
- DCF 1
- Return on Equity 5
- Return on Assets 5
- Debt / Equity 2
- P/E 3
- P/B 2
Valuation
P/E 29.4×
FY 2016 5y median -2.3× FY 2025
P/S 8.5×
FY 2016 5y median 5.0× FY 2025
P/B 9.1×
FY 2016 5y median 7.5× FY 2025
P/FCF 156×
FY 2016 5y median 36.3× FY 2025
EV/EBITDA 21.9×
FY 2016 5y median 21.9× FY 2025
EV/Sales 8.5×
FY 2016 5y median 5.4× FY 2025
FCF Yield 0.6%
FY 2016 5y median 0.4% FY 2025
Profitability
Gross Margin 57.4%
FY 2016 5y median 34.4% FY 2025
Operating Margin 37.5%
FY 2016 5y median 8.4% FY 2025
Net Margin 28.8%
FY 2016 5y median -10.9% FY 2025
ROE 30.8%
FY 2016 5y median -20.9% FY 2025
ROIC 27.6%
FY 2016 5y median 7.7% FY 2025
ROA 23.5%
FY 2016 5y median -8.6% FY 2025
Growth (YoY)
Revenue 19.6%
FY 2016 FY 2025
Operating Income 37.7%
FY 2016 FY 2025
EPS (diluted) -25.9%
FY 2016 FY 2025
Free Cash Flow -74.7%
FY 2016 FY 2025
Financial Health
Current Ratio 6.7×
FY 2016 5y median 6.7× FY 2025
Quick Ratio 3.7×
FY 2016 5y median 2.8× FY 2025
Debt / Equity 0.2×
FY 2016 5y median 0.7× FY 2025
Net Debt / EBITDA -0.0×
FY 2016 5y median -0.1× FY 2025
Interest Coverage 26.9×
FY 2016 5y median 0.9× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
